Concepedia

Prognostic significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapy

Richie Soong, Nilesh Shah, Manuel Salto‐Tellez, Bee‐Choo Tai, Ross A. Soo, Han Han, S.S. Ng, Wenming Tan, Nikolajs Zeps, David Joseph,

Annals of Oncology · 2008 · 136 citations · 23 references

DOIFull text

Open access

Concepts

References

23

Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer

Christine Ribic, Daniel J. Sargent, Malcolm J. Moore et al. · New England Journal of Medicine · 2003 · 2.1K citations · Full text

, , +15

ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer

Gershon Y. Locker, Stanley R. Hamilton, Jules E. Harris et al. · Journal of Clinical Oncology · 2006 · 1.6K citations

, , +8

Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final Report

Charles G. Moertel · Annals of Internal Medicine · 1995 · 934 citations

, , +17

Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase.

Dennis Salonga, Kathleen D. Danenberg, Martin R. Johnson et al. · PubMed · 2000 · 834 citations

, , +16

Thymidylate Synthase Expression in Colorectal Cancer: A Prognostic and Predictive Marker of Benefit From Adjuvant Fluorouracil-Based Chemotherapy

David Edler, Bengt Glimelius, Marja Hallström et al. · Journal of Clinical Oncology · 2002 · 263 citations

, , +14